ERBB2 and breast cancer: High expression of genes typical for lymphocytes (such as CD8) and low expression of genes typical of myeloid cells (such as CD68) was found to indicate better prognosis, especially in basal like and HER-2/neu positive breast cancer subtypes [8–10].